 Csaba Galambos
Concepts (483)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Alveoli | 16 | 2023 | 405 | 2.840 |
Why?
| | Persistent Fetal Circulation Syndrome | 10 | 2023 | 137 | 2.720 |
Why?
| | Lung | 31 | 2024 | 4060 | 2.410 |
Why?
| | Respiratory Insufficiency | 6 | 2023 | 318 | 2.360 |
Why?
| | Pulmonary Artery | 11 | 2021 | 1086 | 2.290 |
Why?
| | Pulmonary Veins | 5 | 2019 | 99 | 1.750 |
Why?
| | Arteriovenous Anastomosis | 4 | 2022 | 13 | 1.650 |
Why?
| | Bronchial Arteries | 3 | 2018 | 12 | 1.640 |
Why?
| | Bronchi | 6 | 2023 | 260 | 1.470 |
Why?
| | Hypertension, Pulmonary | 17 | 2024 | 1910 | 1.410 |
Why?
| | Pulmonary Circulation | 7 | 2022 | 429 | 1.230 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 19 | 1.150 |
Why?
| | Down Syndrome | 6 | 2021 | 496 | 1.100 |
Why?
| | Infant, Newborn | 37 | 2024 | 6079 | 1.060 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2023 | 198 | 1.020 |
Why?
| | T-Box Domain Proteins | 3 | 2023 | 98 | 1.000 |
Why?
| | Immunohistochemistry | 13 | 2017 | 1738 | 0.990 |
Why?
| | Lung Diseases | 9 | 2024 | 767 | 0.990 |
Why?
| | Homeodomain Proteins | 4 | 2017 | 506 | 0.970 |
Why?
| | Infant | 38 | 2025 | 9465 | 0.960 |
Why?
| | Bronchopulmonary Dysplasia | 3 | 2024 | 383 | 0.910 |
Why?
| | Lung Diseases, Interstitial | 6 | 2021 | 638 | 0.900 |
Why?
| | Abnormalities, Multiple | 3 | 2016 | 189 | 0.900 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 3 | 2014 | 52 | 0.830 |
Why?
| | Lymphatic Vessels | 3 | 2009 | 64 | 0.810 |
Why?
| | Heart Defects, Congenital | 6 | 2022 | 842 | 0.800 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 172 | 0.780 |
Why?
| | Cardiovascular Abnormalities | 1 | 2022 | 13 | 0.770 |
Why?
| | Sudden Infant Death | 1 | 2022 | 29 | 0.770 |
Why?
| | Capillaries | 3 | 2014 | 108 | 0.720 |
Why?
| | Humans | 92 | 2025 | 137585 | 0.670 |
Why?
| | Mutation | 13 | 2025 | 3958 | 0.640 |
Why?
| | Tumor Suppressor Proteins | 3 | 2011 | 327 | 0.630 |
Why?
| | Graft Rejection | 5 | 2013 | 624 | 0.620 |
Why?
| | Histological Techniques | 2 | 2009 | 40 | 0.620 |
Why?
| | Death, Sudden | 1 | 2019 | 24 | 0.610 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 156 | 0.600 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 86 | 0.590 |
Why?
| | Child, Preschool | 25 | 2021 | 11074 | 0.590 |
Why?
| | Fatal Outcome | 7 | 2019 | 303 | 0.580 |
Why?
| | Gene Deletion | 1 | 2019 | 391 | 0.560 |
Why?
| | Pneumonia | 2 | 2022 | 639 | 0.560 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.550 |
Why?
| | Child | 36 | 2023 | 21935 | 0.540 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.530 |
Why?
| | Imaging, Three-Dimensional | 4 | 2019 | 580 | 0.530 |
Why?
| | Virus Diseases | 2 | 2009 | 212 | 0.520 |
Why?
| | Collagen Type VIII | 1 | 2016 | 3 | 0.520 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2016 | 9 | 0.520 |
Why?
| | Collagen Type IV | 1 | 2016 | 28 | 0.510 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2016 | 66 | 0.500 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2024 | 201 | 0.490 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2015 | 11 | 0.490 |
Why?
| | Veins | 1 | 2016 | 63 | 0.490 |
Why?
| | Male | 51 | 2025 | 67762 | 0.480 |
Why?
| | Microvessels | 1 | 2016 | 88 | 0.460 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 270 | 0.460 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 215 | 0.460 |
Why?
| | Sarcoma | 1 | 2017 | 188 | 0.450 |
Why?
| | Arteriovenous Fistula | 1 | 2014 | 36 | 0.440 |
Why?
| | Hypoxia | 2 | 2019 | 1112 | 0.420 |
Why?
| | Autoantigens | 1 | 2016 | 430 | 0.410 |
Why?
| | Transcription Factors | 3 | 2023 | 1719 | 0.410 |
Why?
| | Female | 44 | 2024 | 73304 | 0.410 |
Why?
| | Nuclear Proteins | 2 | 2010 | 712 | 0.400 |
Why?
| | Lymphangiogenesis | 2 | 2011 | 27 | 0.400 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 7 | 0.390 |
Why?
| | Endothelium, Lymphatic | 3 | 2009 | 12 | 0.390 |
Why?
| | ABO Blood-Group System | 2 | 2011 | 51 | 0.380 |
Why?
| | Complement C4b | 2 | 2013 | 9 | 0.380 |
Why?
| | Tomography, X-Ray Computed | 8 | 2022 | 2691 | 0.380 |
Why?
| | Antibodies, Monoclonal | 3 | 2009 | 1430 | 0.370 |
Why?
| | Sensitivity and Specificity | 6 | 2017 | 1946 | 0.360 |
Why?
| | Heart Neoplasms | 2 | 2022 | 50 | 0.360 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1276 | 0.360 |
Why?
| | Diagnosis, Differential | 8 | 2017 | 1483 | 0.350 |
Why?
| | Biomarkers | 8 | 2024 | 4149 | 0.340 |
Why?
| | Erythema | 1 | 2010 | 29 | 0.340 |
Why?
| | Vena Cava, Superior | 1 | 2010 | 23 | 0.340 |
Why?
| | Teratoma | 2 | 2025 | 114 | 0.340 |
Why?
| | Forkhead Transcription Factors | 3 | 2023 | 191 | 0.330 |
Why?
| | Phosphoproteins | 2 | 2018 | 338 | 0.330 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2010 | 37 | 0.330 |
Why?
| | Vena Cava, Inferior | 1 | 2010 | 71 | 0.320 |
Why?
| | Scalp | 2 | 2010 | 35 | 0.320 |
Why?
| | Ranula | 1 | 2009 | 3 | 0.320 |
Why?
| | Mucocele | 1 | 2009 | 12 | 0.310 |
Why?
| | Pleural Effusion | 2 | 2021 | 54 | 0.310 |
Why?
| | Blood Group Antigens | 1 | 2009 | 15 | 0.300 |
Why?
| | Pathology | 1 | 2009 | 24 | 0.300 |
Why?
| | Asthma | 2 | 2021 | 2295 | 0.300 |
Why?
| | Hemodynamics | 5 | 2021 | 1113 | 0.300 |
Why?
| | Adolescent | 18 | 2025 | 21513 | 0.290 |
Why?
| | Vascular Malformations | 1 | 2009 | 52 | 0.290 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2021 | 45 | 0.290 |
Why?
| | Cryopreservation | 1 | 2009 | 100 | 0.280 |
Why?
| | Peptide Fragments | 2 | 2013 | 706 | 0.280 |
Why?
| | Viruses | 1 | 2009 | 113 | 0.280 |
Why?
| | Endocardium | 1 | 2007 | 35 | 0.280 |
Why?
| | Phenotype | 5 | 2023 | 3196 | 0.270 |
Why?
| | Heart Transplantation | 3 | 2013 | 754 | 0.270 |
Why?
| | Hemorrhage | 2 | 2021 | 722 | 0.260 |
Why?
| | Infant, Premature | 3 | 2023 | 574 | 0.250 |
Why?
| | Heart Ventricles | 4 | 2022 | 788 | 0.250 |
Why?
| | Temporal Muscle | 1 | 2005 | 3 | 0.250 |
Why?
| | Vascular Resistance | 2 | 2019 | 375 | 0.240 |
Why?
| | Biopsy | 9 | 2024 | 1129 | 0.240 |
Why?
| | Choristoma | 1 | 2005 | 21 | 0.240 |
Why?
| | Herpesvirus 8, Human | 1 | 2006 | 65 | 0.240 |
Why?
| | Neovascularization, Physiologic | 1 | 2007 | 179 | 0.240 |
Why?
| | Thyroid Nuclear Factor 1 | 2 | 2019 | 16 | 0.240 |
Why?
| | Young Adult | 7 | 2023 | 13209 | 0.240 |
Why?
| | Submandibular Gland | 1 | 2025 | 20 | 0.240 |
Why?
| | Nose Neoplasms | 1 | 2025 | 25 | 0.230 |
Why?
| | Carcinosarcoma | 1 | 2025 | 21 | 0.230 |
Why?
| | Interleukin-5 | 1 | 2025 | 44 | 0.230 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 26 | 0.230 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 382 | 0.230 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2024 | 26 | 0.220 |
Why?
| | Microscopy, Phase-Contrast | 2 | 2021 | 18 | 0.220 |
Why?
| | Synchrotrons | 2 | 2021 | 13 | 0.220 |
Why?
| | Disease Models, Animal | 6 | 2019 | 4295 | 0.220 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 94 | 0.210 |
Why?
| | Soft Tissue Neoplasms | 1 | 2005 | 115 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2025 | 804 | 0.210 |
Why?
| | Hemangiopericytoma | 1 | 2003 | 5 | 0.200 |
Why?
| | DNA Copy Number Variations | 2 | 2025 | 182 | 0.200 |
Why?
| | Aorta | 2 | 2019 | 417 | 0.200 |
Why?
| | Infant Death | 1 | 2022 | 6 | 0.200 |
Why?
| | Lung Transplantation | 2 | 2019 | 313 | 0.200 |
Why?
| | Arteriovenous Malformations | 1 | 2022 | 27 | 0.190 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.190 |
Why?
| | Severity of Illness Index | 5 | 2018 | 2828 | 0.190 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.190 |
Why?
| | Fibrin | 1 | 2023 | 81 | 0.190 |
Why?
| | Lymphokines | 1 | 2002 | 131 | 0.190 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 51 | 0.190 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 43 | 0.190 |
Why?
| | Serotonin | 1 | 2024 | 323 | 0.190 |
Why?
| | Myocardium | 2 | 2017 | 1002 | 0.180 |
Why?
| | Antibodies, Viral | 1 | 2006 | 625 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2019 | 2475 | 0.180 |
Why?
| | Epilepsy | 1 | 2005 | 333 | 0.180 |
Why?
| | Consensus | 1 | 2024 | 683 | 0.180 |
Why?
| | Sjogren's Syndrome | 1 | 2021 | 54 | 0.180 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 21 | 0.170 |
Why?
| | Protein C | 1 | 2021 | 59 | 0.170 |
Why?
| | Vascular Remodeling | 2 | 2021 | 193 | 0.170 |
Why?
| | Vasculitis | 1 | 2021 | 66 | 0.170 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 118 | 0.160 |
Why?
| | Pulmonary Heart Disease | 1 | 2019 | 6 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 225 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2021 | 162 | 0.160 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.160 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2019 | 27 | 0.150 |
Why?
| | Mitochondrial Diseases | 1 | 2020 | 91 | 0.150 |
Why?
| | Adult | 9 | 2023 | 37929 | 0.150 |
Why?
| | Case-Control Studies | 5 | 2024 | 3556 | 0.150 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2018 | 19 | 0.150 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 27 | 0.150 |
Why?
| | Heterozygote | 1 | 2019 | 293 | 0.150 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 22 | 0.150 |
Why?
| | Catheterization, Swan-Ganz | 1 | 2018 | 9 | 0.150 |
Why?
| | Silicosis | 1 | 2018 | 27 | 0.150 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2018 | 28 | 0.150 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.150 |
Why?
| | Retrospective Studies | 9 | 2021 | 15657 | 0.140 |
Why?
| | Gene Expression | 1 | 2023 | 1502 | 0.140 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 259 | 0.140 |
Why?
| | Nervous System Malformations | 1 | 2018 | 42 | 0.140 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.140 |
Why?
| | Histiocytosis | 1 | 2017 | 7 | 0.140 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 97 | 0.140 |
Why?
| | Macrophages, Alveolar | 2 | 2012 | 391 | 0.140 |
Why?
| | Contracture | 1 | 2017 | 20 | 0.140 |
Why?
| | Early Medical Intervention | 1 | 2018 | 57 | 0.140 |
Why?
| | Pleurisy | 1 | 2017 | 5 | 0.140 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 22 | 0.140 |
Why?
| | Uremia | 1 | 2017 | 16 | 0.140 |
Why?
| | Up-Regulation | 2 | 2020 | 843 | 0.140 |
Why?
| | Heart Failure | 3 | 2021 | 2236 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2004 | 3015 | 0.140 |
Why?
| | Coccyx | 1 | 2017 | 4 | 0.130 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 7 | 0.130 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2017 | 67 | 0.130 |
Why?
| | Developmental Disabilities | 1 | 2020 | 263 | 0.130 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 56 | 0.130 |
Why?
| | Collagen Type XVIII | 1 | 2016 | 5 | 0.130 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 395 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2023 | 1164 | 0.130 |
Why?
| | Syndrome | 2 | 2010 | 358 | 0.130 |
Why?
| | Myocardial Contraction | 1 | 2018 | 341 | 0.130 |
Why?
| | Sacrum | 1 | 2017 | 67 | 0.130 |
Why?
| | Cadaver | 2 | 2015 | 296 | 0.120 |
Why?
| | Kidney | 2 | 2022 | 1468 | 0.120 |
Why?
| | Multiple Myeloma | 1 | 2019 | 252 | 0.120 |
Why?
| | Autopsy | 1 | 2016 | 95 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 622 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 449 | 0.120 |
Why?
| | Cell Transdifferentiation | 1 | 2015 | 31 | 0.120 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 101 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 285 | 0.120 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2015 | 59 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2020 | 771 | 0.120 |
Why?
| | Marijuana Smoking | 1 | 2018 | 252 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 657 | 0.120 |
Why?
| | Pancreatic Ducts | 1 | 2015 | 85 | 0.110 |
Why?
| | Muscle Proteins | 1 | 2016 | 231 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2003 | 938 | 0.110 |
Why?
| | Adventitia | 1 | 2014 | 40 | 0.110 |
Why?
| | Alanine Transaminase | 2 | 2013 | 157 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 247 | 0.110 |
Why?
| | Algorithms | 1 | 2022 | 1704 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 767 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 991 | 0.110 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2013 | 14 | 0.110 |
Why?
| | Macaca fascicularis | 1 | 2013 | 65 | 0.110 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.110 |
Why?
| | Pregnancy | 4 | 2019 | 6763 | 0.110 |
Why?
| | I-kappa B Proteins | 1 | 2014 | 81 | 0.100 |
Why?
| | Brain | 1 | 2005 | 2668 | 0.100 |
Why?
| | Adenofibroma | 1 | 2013 | 2 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 385 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2016 | 455 | 0.100 |
Why?
| | Hyperoxia | 1 | 2014 | 90 | 0.100 |
Why?
| | Infant, Extremely Premature | 1 | 2013 | 66 | 0.100 |
Why?
| | Animals | 12 | 2023 | 36940 | 0.100 |
Why?
| | Mucin-5B | 1 | 2015 | 224 | 0.100 |
Why?
| | Hepatocytes | 1 | 2013 | 220 | 0.100 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1774 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 150 | 0.100 |
Why?
| | Osteopetrosis | 1 | 2012 | 1 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 652 | 0.100 |
Why?
| | Mandibular Neoplasms | 1 | 2012 | 25 | 0.090 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2012 | 16 | 0.090 |
Why?
| | Nephrectomy | 1 | 2013 | 169 | 0.090 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 27 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1692 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 60 | 0.090 |
Why?
| | Glycogen Storage Disease Type III | 1 | 2011 | 1 | 0.090 |
Why?
| | Blood Group Incompatibility | 1 | 2011 | 15 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 860 | 0.090 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 416 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 78 | 0.090 |
Why?
| | Transplants | 1 | 2011 | 36 | 0.090 |
Why?
| | Lung Injury | 1 | 2014 | 219 | 0.090 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 377 | 0.090 |
Why?
| | Prognosis | 4 | 2021 | 4030 | 0.090 |
Why?
| | Mannose-Binding Lectins | 1 | 2010 | 11 | 0.090 |
Why?
| | Sympathetic Nervous System | 1 | 2011 | 182 | 0.090 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2010 | 13 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1996 | 0.080 |
Why?
| | Antigens, CD1 | 1 | 2010 | 58 | 0.080 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2010 | 3 | 0.080 |
Why?
| | Lectins, C-Type | 1 | 2010 | 67 | 0.080 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 35 | 0.080 |
Why?
| | Multiple Organ Failure | 2 | 2012 | 128 | 0.080 |
Why?
| | Thyroid Diseases | 1 | 2010 | 36 | 0.080 |
Why?
| | MicroRNAs | 1 | 2016 | 692 | 0.080 |
Why?
| | NF-kappa B | 1 | 2014 | 691 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 816 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 2015 | 803 | 0.080 |
Why?
| | Vascular Stiffness | 1 | 2014 | 494 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 99 | 0.080 |
Why?
| | Tissue Preservation | 1 | 2009 | 12 | 0.080 |
Why?
| | Antigens, CD34 | 1 | 2009 | 88 | 0.080 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 69 | 0.080 |
Why?
| | Ki-67 Antigen | 1 | 2009 | 112 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 6828 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2011 | 363 | 0.080 |
Why?
| | Sampling Studies | 1 | 2009 | 99 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1502 | 0.080 |
Why?
| | Face | 1 | 2010 | 173 | 0.070 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 126 | 0.070 |
Why?
| | Disease Management | 1 | 2013 | 628 | 0.070 |
Why?
| | Brain Diseases | 1 | 2010 | 141 | 0.070 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 403 | 0.070 |
Why?
| | Acute Disease | 1 | 2011 | 1007 | 0.070 |
Why?
| | Hip Joint | 1 | 2010 | 171 | 0.070 |
Why?
| | Papillomaviridae | 1 | 2009 | 125 | 0.070 |
Why?
| | Adenoviridae | 1 | 2009 | 193 | 0.070 |
Why?
| | Blood-Air Barrier | 1 | 2008 | 11 | 0.070 |
Why?
| | Cytomegalovirus | 1 | 2009 | 157 | 0.070 |
Why?
| | Paraffin Embedding | 1 | 2007 | 32 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2025 | 594 | 0.070 |
Why?
| | Antigens, CD | 1 | 2010 | 521 | 0.070 |
Why?
| | Pulmonary Valve | 1 | 2009 | 97 | 0.070 |
Why?
| | Hormones | 1 | 2008 | 143 | 0.070 |
Why?
| | Middle Aged | 5 | 2016 | 33479 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 331 | 0.060 |
Why?
| | Lower Extremity | 1 | 2010 | 427 | 0.060 |
Why?
| | Fetal Death | 1 | 2006 | 55 | 0.060 |
Why?
| | Graft Survival | 1 | 2009 | 535 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3284 | 0.060 |
Why?
| | Sequence Deletion | 2 | 2022 | 183 | 0.060 |
Why?
| | Liver | 1 | 2013 | 1943 | 0.060 |
Why?
| | Insulin | 1 | 2015 | 2409 | 0.060 |
Why?
| | Rhabdomyosarcoma | 1 | 2005 | 72 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2553 | 0.060 |
Why?
| | Specimen Handling | 1 | 2006 | 183 | 0.060 |
Why?
| | Fetal Development | 1 | 2008 | 296 | 0.060 |
Why?
| | Treatment Outcome | 4 | 2025 | 10811 | 0.060 |
Why?
| | Neuroglia | 1 | 2005 | 173 | 0.060 |
Why?
| | Fibrosis | 2 | 2017 | 552 | 0.060 |
Why?
| | Sheep | 2 | 2019 | 856 | 0.050 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 173 | 0.050 |
Why?
| | Comorbidity | 2 | 2020 | 1622 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 785 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 240 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2004 | 204 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2031 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 253 | 0.050 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 79 | 0.050 |
Why?
| | Creatinine | 1 | 2024 | 499 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2022 | 14 | 0.050 |
Why?
| | Mouth Mucosa | 1 | 2022 | 92 | 0.050 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2002 | 10 | 0.050 |
Why?
| | Mosaicism | 1 | 2022 | 73 | 0.050 |
Why?
| | Models, Anatomic | 1 | 2002 | 93 | 0.050 |
Why?
| | Myeloproliferative Disorders | 1 | 2002 | 27 | 0.050 |
Why?
| | Plasma Cells | 1 | 2002 | 71 | 0.050 |
Why?
| | Mice | 4 | 2014 | 17787 | 0.050 |
Why?
| | Lymphoproliferative Disorders | 1 | 2002 | 57 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2019 | 318 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2003 | 100 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 404 | 0.040 |
Why?
| | Heparin | 1 | 2002 | 261 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 69 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 91 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 92 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2002 | 229 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 138 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 209 | 0.040 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2020 | 44 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 518 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 545 | 0.040 |
Why?
| | Risk Factors | 3 | 2020 | 10388 | 0.040 |
Why?
| | Tumor Hypoxia | 1 | 2019 | 7 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 927 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 631 | 0.040 |
Why?
| | Coronary Occlusion | 1 | 2019 | 19 | 0.040 |
Why?
| | Risk Assessment | 1 | 2009 | 3457 | 0.040 |
Why?
| | Signal Transduction | 3 | 2019 | 5079 | 0.040 |
Why?
| | Interleukin-15 | 1 | 2019 | 98 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 203 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.040 |
Why?
| | Age Factors | 2 | 2016 | 3295 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2019 | 126 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 332 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 52 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 228 | 0.040 |
Why?
| | Nucleoside Transport Proteins | 1 | 2017 | 7 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1236 | 0.040 |
Why?
| | Tumor Burden | 1 | 2019 | 309 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.030 |
Why?
| | Azathioprine | 1 | 2017 | 54 | 0.030 |
Why?
| | Interleukin-2 | 1 | 2019 | 455 | 0.030 |
Why?
| | Pleura | 1 | 2017 | 23 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 392 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 375 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 470 | 0.030 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 192 | 0.030 |
Why?
| | Risk | 1 | 2020 | 912 | 0.030 |
Why?
| | Prosthesis Failure | 1 | 2018 | 123 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 513 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 19 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2017 | 56 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2006 | 5131 | 0.030 |
Why?
| | Prednisone | 1 | 2017 | 240 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 346 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 344 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 600 | 0.030 |
Why?
| | Neurons | 1 | 2005 | 1590 | 0.030 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2017 | 121 | 0.030 |
Why?
| | Methotrexate | 1 | 2017 | 260 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 275 | 0.030 |
Why?
| | Radiography | 1 | 2018 | 822 | 0.030 |
Why?
| | Heart | 1 | 2020 | 655 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 327 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 844 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 103 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 526 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 298 | 0.030 |
Why?
| | Neoplasms | 1 | 2010 | 2671 | 0.030 |
Why?
| | Disease Progression | 2 | 2019 | 2757 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 910 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 104 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 674 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2015 | 179 | 0.030 |
Why?
| | North America | 1 | 2015 | 313 | 0.030 |
Why?
| | Elastin | 1 | 2014 | 78 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.030 |
Why?
| | United States | 3 | 2018 | 14841 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 806 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 202 | 0.030 |
Why?
| | Retreatment | 1 | 2013 | 72 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 119 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1570 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2019 | 915 | 0.030 |
Why?
| | Stents | 1 | 2018 | 527 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 232 | 0.030 |
Why?
| | Regeneration | 1 | 2015 | 197 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 80 | 0.030 |
Why?
| | Gene Order | 1 | 2013 | 26 | 0.030 |
Why?
| | Cohort Studies | 2 | 2018 | 5742 | 0.030 |
Why?
| | Albumins | 1 | 2013 | 114 | 0.030 |
Why?
| | Liver Failure, Acute | 1 | 2013 | 67 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 148 | 0.030 |
Why?
| | Pancreatectomy | 1 | 2015 | 253 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 908 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1793 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2016 | 965 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2013 | 123 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Gene Dosage | 1 | 2013 | 140 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2013 | 343 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2013 | 179 | 0.020 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 4 | 0.020 |
Why?
| | Phenyl Ethers | 1 | 2011 | 4 | 0.020 |
Why?
| | Collagen | 1 | 2014 | 452 | 0.020 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 2011 | 11 | 0.020 |
Why?
| | S100 Proteins | 1 | 2011 | 37 | 0.020 |
Why?
| | Wilms Tumor | 1 | 2013 | 86 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 523 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2013 | 237 | 0.020 |
Why?
| | Hemagglutinins | 1 | 2011 | 9 | 0.020 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 65 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2734 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3412 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2012 | 132 | 0.020 |
Why?
| | Isoantibodies | 1 | 2011 | 60 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 176 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2012 | 286 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2010 | 57 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 528 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1250 | 0.020 |
Why?
| | Radiosurgery | 1 | 2013 | 344 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2167 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 2074 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1916 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 2012 | 252 | 0.020 |
Why?
| | HLA Antigens | 1 | 2011 | 240 | 0.020 |
Why?
| | Shock, Septic | 1 | 2012 | 219 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1710 | 0.020 |
Why?
| | Arthralgia | 1 | 2010 | 56 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2003 | 2526 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 985 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2139 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 563 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1096 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2900 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5757 | 0.020 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2015 | 657 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 658 | 0.020 |
Why?
| | Endocrine System Diseases | 1 | 2007 | 35 | 0.020 |
Why?
| | Growth Disorders | 1 | 2007 | 86 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2007 | 106 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 137 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7604 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2007 | 216 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2085 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2007 | 266 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2607 | 0.010 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 815 | 0.010 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2002 | 15 | 0.010 |
Why?
| | Purpura | 1 | 2002 | 17 | 0.010 |
Why?
| | Karyotyping | 1 | 2002 | 104 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 83 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2002 | 164 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 175 | 0.010 |
Why?
| | Bone Marrow | 1 | 2002 | 286 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2002 | 200 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 1062 | 0.010 |
Why?
| | RNA, Viral | 1 | 2002 | 656 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2002 | 1178 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3566 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2654 | 0.010 |
Why?
|
|
Galambos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|